Product Information

ARNUITY ELLIPTA 200 MCG INH is a brand product labeled by GlaxoSmithKline LLC, priced at $8.8925 per EA under NDC 00173087610. Its NADAC has been published 592 times since Jul 22, 2015.

FDA first approved this application on Aug 20, 2014.

ARNUITY ELLIPTA 200 MCG INH

fluticasone furoate
$8.8925per EA

Strength

200 ug/1

NDC

00173087610

Classification

Brand

Dosage Form

POWDER

Route

RESPIRATORY (INHALATION)

Effective Date

11/18/2026

Active Ingredients

FLUTICASONE FUROATE

Approval Type

New Drug (NDA)

FDA Application

NDA205625

FDA Approved

8/20/2014

On Market Since

8/20/2014

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for ARNUITY ELLIPTA 200 MCG INH has been published 592 times since Jul 22, 2015, and over the history we have for it it has risen 59.1%. The table below summarizes its recorded NADAC range and movement.

Current price$8.8925 per EA
All-time high$8.9289 (Sep 11, 2024)
All-time low$5.5881 (Jul 22, 2015)
52-week high$8.9092
52-week low$8.8925
Median price$7.8673
Average price$7.8485
Largest weekly change+8.5% (Dec 30, 2015)
Weeks tracked592
Tracking sinceJul 22, 2015

Price History

1W

-0.0%

1M

-0.0%

3M

-0.0%

6M

-0.1%

1Y

-0.2%

3Y

-0.3%

5Y

+12.9%

All

+59.1%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 35% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ARNUITY ELLIPTA 200 MCG INH?

The current National Average Drug Acquisition Cost (NADAC) for ARNUITY ELLIPTA 200 MCG INH, manufactured by GlaxoSmithKline LLC, is $8.8925 per EA (NDC 00173087610), effective Nov 18, 2026.

How has the price of ARNUITY ELLIPTA 200 MCG INH changed over time?

Over the history we have for it, the NADAC for ARNUITY ELLIPTA 200 MCG INH has risen 59.1%. It has been tracked across 592 weekly CMS publications since Jul 22, 2015.

What are the highest and lowest recorded NADAC prices for ARNUITY ELLIPTA 200 MCG INH?

Since Jul 22, 2015, the NADAC for ARNUITY ELLIPTA 200 MCG INH has ranged from a low of $5.5881 (Jul 22, 2015) to a high of $8.9289 (Sep 11, 2024), with a median of $7.8673 per EA.

Are there cheaper alternatives to ARNUITY ELLIPTA 200 MCG INH?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FLUTICASONE ELLIPTA 200 MCG INH, is $5.7424 per EA — about 35% below ARNUITY ELLIPTA 200 MCG INH.

Who manufactures ARNUITY ELLIPTA 200 MCG INH?

ARNUITY ELLIPTA 200 MCG INH (NDC 00173087610) is labeled by GlaxoSmithKline LLC, and CMS classifies it as a brand product.